NOV 14 - 15 2018
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
6th annual 24 Hours of Stem Cells™ virtual event
3 4 768

Register for free to attend the 6th annual Gibco™ 24 Hours of Stem Cells™ virtual event, the largest global virtual stem cell event taking place around the world on November 15, 2018*.

During 24 Hours of Stem Cells, you can:

  • Access leading scientific presentations from thought leaders around the world
  • Receive real-time training, tips and technical support from our stem cell experts
  • Sharpen your stem cell skills and expertise with virtual training and certifications
  • Expand your research network and enrich your perspective in a global context

Experience all of this virtually, from the comfort of anywhere. Register today.

*Event hours: Log in any time after 8:00AM November 15th regardless of your time zone.

 

What attendees liked about last year's event Explore the virtual event

 


If you have additional questions, please contact Chelsie Fritz at chelsie.fritz@thermofisher.com.


Speakers:
  • Scientist, Diabetes Research Center - QBRI, and Assistant Professor, College of Science and Engineering, HBKU
  • FCT Investigator, Instituto de Medicina Molecular (IMM), Faculdade de Medicina da Universidade de Lisboa
  • Stadtman Investigator, NIH, Unit on Ocular Stem Cell & Translational Research
  • Co-founder, ADCY5
  • Instructor in Neurology, Harvard Medical School
  • Associate Director - Stem & Primary Cell Group, AstraZeneca
  • Professor of Developmental Neurobiology Director of the Center for Regenerative Medicine, The Scripps Research Institute
  • Senior Scientist, Cell and Gene Therapy Catapult
  • Professor, Department of Pediatrics/Cellular & Molecular Medicine, University of California, San Diego
  • Director, Neural Stem Cell Research Investigator, Program in Neuroscience, Hussman Institute for Autism
  • Chief Technology Scientist, Centre for Brain development and Repair, Instem, Bangalore
  • Chief Technology Scientist, Centre for Brain development and Repair, Instem, Bangalore
  • Head of Research Professor of Biomedical Sciences, D'Or Institute for Research and Education (IDOR) & Institute of Biomedical Sciences Federal University of Rio de Janeiro
  • Senior Scientist, Roche
  • Assistant Professor, Department of Biomedical Engineering, Wisconsin Institute for Discovery, University of Wisconsin-Madison
  • Assistant Professor, Department of Genetics and Genome Sciences, Case Western Reserve University
  • Postdoctoral Research Associate, Lead ID, The Scripps Research Institute
  • ARC DECRA Fellow, University of Melbourne
  • Associate Director, CuSTOM, Professor and Assistant Professor, Cincinnati Children's Hospital Tokyo Medical and Dental University Yokohama City University, Principal Investigator, Takeda-CiRA
  • CEO/Founder, RARE Science

Show Resources
Webinars
Click below each speaker's photo to watch their Webcast
Speakers

  • Essam Abdelalim
    Scientist, Diabetes Research Center - QBRI, and Assistant Professor, College of Science and Engineering, HBKU
    Biography
      Dr. Essam M. Abdelalim is a scientist at QBRI and Assistant Professor at Hamad Bin Khalifa University (HBKU). He received his Ph.D. in Medical Science from Shiga University of Medical Science, Japan, and was later appointed as Assistant Professor in the same university. He was awarded a Postdoctoral Fellowship from the Japan Society for Promotion of Science (JSPS), where he identified novel genes involved in maintaining pluripotency and self-renewal of embryonic stem cells (ESCs). Since April 2014, Dr. Abdelalim has been leading the stem cell team focusing on diabetes at QBRI/HBKU. He has received several prestigious awards, including the State Prize of Encouragement (Egypt) in 2012 and the President's Award for outstanding PhD student from Shiga University of Medical Science (Japan) in 2007. Dr. Abdelalim is a member of the editorial board of "Stem Cells and Development" and "World Journal of Stem Cells". He is also a guest editor for "Stem Cell International" and "Frontiers in Cell and Developmental Biology". His current research at QBRI focuses on using pluripotent stem cell technology to investigate the pathophysiology underlying the development of diabetes and insulin resistance as well as generating stem cell-derived pancreatic beta cells for cellular therapy. He is currently leading several diabetes-related projects funded by QBRI and QNRF. Recently, he has been awarded two NPRP grants (NPRP9 and NPRP10) and two QBRI Internal Research grants to study diabetes and pancreatic beta cell differentiation.
    • Bruno Bernardes de Jesus, PhD
      FCT Investigator, Instituto de Medicina Molecular (IMM), Faculdade de Medicina da Universidade de Lisboa
      Biography
        Bruno Bernardes de Jesus is a FCT Investigator at the unit of Dr. Carmo-Fonseca, Instituto de Medicina Molecular (IMM), Faculdade de Medicina da Universidade de Lisboa, Lisboa, since 2015. From 2013 to 2015, he was a Post-Doctoral fellow in the unit of Dr. Carmo-Fonseca, Cell Biology Division at the Instituto de Medicina Molecular (IMM), Faculdade de Medicina da Universidade de Lisboa and, before that, from 2009 to 2013, Bruno was a Post-Doctoral fellow under the supervision of Dr. Maria A. Blasco, head of the Telomeres and Telomerase Laboratory, and Director of the Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Bruno got his PhD in Molecular and Cellular Biology (University Louis Pasteur) at the Functional Genomic Department, IGBMC, Strasbourg, France, during 2008 and under supervision of Prof. Jean-Marc Egly. Bruno has a BSc in Biochemistry from the Faculty of Sciences and Technology, University of Coimbra, Portugal (1998 to 2003). Bruno Bernardes de Jesus principal research interests are Aging, stem cell biology, telomerase, cancer and lncRNAs. Bruno was the author of several scientific papers and patents on those research areas. Additionally, he collaborated in several MSc and PhD programs.
      • Kapil Bharti
        Stadtman Investigator, NIH, Unit on Ocular Stem Cell & Translational Research
        Biography
          Dr. Kapil Bharti holds a bachelor's degree in Biophysics from the Panjab University, Chandigarh, India, a master's degree in biotechnology from the M.S. Rao University, Baroda, India, and a diploma in molecular cell biology from Johann Wolfgang Goethe University, Frankfurt, Germany. He obtained his Ph.D. from the same institution, graduating summa cum laude. His Ph.D. work involved research in the areas of heat stress, chaperones, and epigenetics. He did his postdoc at the National Institutes of Health, where he published numerous papers in the areas of transcription regulation, pigment cell biology, and developmental biology of the eye. He has won several awards, including, most recently, being selected as an Earl Stadtman Tenure-Track Investigator at NIH. His lab was recently awarded two prestigious grants: 1) the only Intramural Common Fund grant to develop a phase I Investigational New Drug (IND) for Autologous induced pluripotent stem cell derived retinal pigment epithelium tissue; and 2) a DoD grant to develop a 3D-retina tissue to model retinal diseases in vitro. His current work as the head of the Unit on Ocular and Stem Cell Translational Research involves understanding mechanism of retinal degenerative diseases using induced pluripotent stem cell technology, and developing cell-based and drug-based therapies for such diseases.
        • Gay Grossman
          Co-founder, ADCY5
          Biography
            Gay started ADCY5.org to provide a place for newly diagnosed families of ADCY5 related-Dyskinesia, an ultra Rare Disease. They currently have one of the largest Rare Disease stem cell projects. Working with biotech partners, almost $3 million has been dedicated to ADCY5 related-Dyskinesia related science through ADCY5.org. Speaking publicly at conferences and to organizations about the first hand experience of Whole Genome Sequencing, personalizes how a diagnosis for her daughter, after 15 years, changed their family's lives. Sharing this story with a variety of audiences including, but not limited to, precision medicine conferences, patient advocacy conferences, and graduate and medical school seminars, fosters partnerships within our community. We Are All Rare, a patient education book Gay co-authored, together with her daughter, who has a Rare Disease, provides an educational tool for families entering primary school, complete with a list of valuable resources. Meeting with her Congressman to encourage support of The OPEN ACT, Medicaid reimbursement, and access for persons with disabilities, gives her the opportunity to share the patient family perspective with policy makers. She is currently serving on the Global Genes Foundation Alliance Advisory Council, their Summit Planning Committee for the 2018 International RARE Patient Advocacy Summit, and on the developing team for the Genetics 101 class. She is an Ambassador for Illumina; for the Rare Undiagnosed Genetic Disease (RUGD) program. Gay works with key opinion leaders like Rare Science, Global Genes, EveryLife Foundation, and other patient advocacy organizations to engage through social media, conferences, and personal networking. Gay started her career in Sales and Sales Training with Glaxo Inc. where she directed a study on Physician Impressions of Corticosteroids and how to best position them in the marketplace. Gay uses this foundation of science and her own experience to relate the burden of disease, bringing awareness through advocacy and public speaking. She successful advocates in environments including, but not limited to, educational classrooms, private, state, and federal insurance, and collaborating in the Rare Disease space to gain access to medical therapies.
          • William Hendriks
            Instructor in Neurology, Harvard Medical School
            Biography
              After receiving his PhD in Neuroscience at the VU University Amsterdam in the Netherlands in 2008, Dr. Hendriks joined the lab of Dr. Paola Arlotta at the Center for Regenerative Medicine of Massachusetts General Hospital (MGH) in Boston to study neuronal development focusing on neuronal differentiation of human pluripotent stem cells. In 2011, Dr. Hendriks joined the Harvard Stem Cell Institute (HSCI) iPS Core facility with Dr. Chad Cowan at Harvard University in Cambridge, where initially he worked on developing and implementing foot-print free somatic cell iPSC reprogramming methods. Dr. Hendriks also initiated and managed the hPSC genome editing service for 2 years at HSCI before moving to his current position as a Harvard Medical School Instructor in Neurology at the MGH Collaborative Center for X-Linked Dystonia Parkinsonism in 2014.
            • Ryan Hicks
              Associate Director - Stem & Primary Cell Group, AstraZeneca
              Biography
                Ryan Hicks is the Associate Director of the Stem & Primary Cell Group at AstraZeneca. Ryan's group is responsible for the generation, engineering and differentiation of iPS cells, adult stem cells and use of primary cells for assay development, target validation, hit finding, hit-to-lead, lead optimization and phenotypic screening activities. Models are generated in 2D and 3D cultures and part of the model development work includes using precise genome modification techniques to introduce gene knock-outs, knock-in mutations or endogenous reporters into iPS cells. The groups work primarily focuses on AstraZeneca's cardiovascular, metabolic, renal and respiratory disease areas. Ryan Hicks joined AstraZeneca in 2001 and has been based in Sweden for the past 8 years. Prior to working in Sweden, Ryan worked as the Associate Director of the Cell & Protein reagents group at AstraZeneca, Alderley Park, UK, with responsibilities in the cell and protein disciplines. Ryan Hicks received his degree in Medical Biochemistry from the University of Birmingham, UK. Following this Ryan received his Ph.D. in Biochemistry and Molecular Biology from the University of Leeds, UK, in 2001.
              • Jeanne Loring
                Professor of Developmental Neurobiology Director of the Center for Regenerative Medicine, The Scripps Research Institute
                Biography
                  Jeanne F. Loring is a Professor and the founding Director of the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla. Her laboratory studies human pluripotent stem cells (hPSCs), the remarkable cells that can make every cell type in the body. Her lab is developing a patient-specific cell replacement therapy for Parkinson's disease and a stem cell-based treatment for multiple sclerosis, and they are studying the underlying causes of autism. With the San Diego Zoo, her lab is developing a "zoo" of induced pluripotent stem cells from endangered species to aid in their conservation. Dr. Loring serves on many scientific and bioethics advisory boards and is frequently quoted in major newspapers, appears on television and in documentary features, and gives many public lectures about science and society. She is particularly concerned with the dangers of unregulated stem cell treatments in the US and other countries ("stem cell tourism"). In 2015, she was designated "Stem Cell Person of the Year" by The Niche blog, and was awarded the Stem Cell Action Advocacy Award by the World Stem Cell Summit.
                • Rhys Macown
                  Senior Scientist, Cell and Gene Therapy Catapult
                  Biography
                    Rhys Macown, Ph.D, is a senior scientist in the process industrialisation team at Cell and Gene Therapy Catapult UK. Rhys earnt a BE(Hons) in chemical and process engineering at University of Canterbury (NZ) before starting his career with a PhD in biochemical engineering in Prof. Nicolas Szita's group at University College London. There he designed and tested a microfluidic system for the 2D adherent culture of pluripotent stem cells with fine control over the micro-environment. Since joining the Cell and Gene Therapy Catapult in 2014, Rhys has been continually active on fee-for-service, collaborative, and core-funded projects developing pluripotent stem cell based processes and has played a leading role exploring the 3D expansion of pluripotent stem cells as aggregates.
                  • Alysson Muotri
                    Professor, Department of Pediatrics/Cellular & Molecular Medicine, University of California, San Diego
                    Biography
                      Dr. Muotri earned a BSc in Biological Sciences from the State University of Campinas in 1995 and a Ph.D. in Genetics in 2001 from University of Sao Paulo, in Brazil. He moved to the Salk Institute as Pew Latin America Fellow in 2002 for a postdoctoral training in the fields of neuroscience and stem cell biology. He has been a Professor at the School of Medicine, University of California in San Diego since late 2008. His research focuses on modeling neurological diseases, such as Autism Spectrum Disorders, using human induced pluripotent stem cells. His lab has developed several techniques to culture human neurons and glia for basic research and drug-screening platforms. He has received several awards, including the prestigious NIH Director's New Innovator Award, NARSAD, Emerald Foundation Young Investigator Award, Surugadai Award from Tokyo University, Rock Star of Innovation from CONNECT, NIH EUREKA Award among others.
                    • Michael Nestor
                      Director, Neural Stem Cell Research Investigator, Program in Neuroscience, Hussman Institute for Autism
                      Biography
                        Dr. Michael W. Nestor is the Director of Neural Stem Cell Research, an Investigator at The Hussman Institute for Autism and Co-Chair, Neural Stem Cell Working Group, Center for Stem Cell Biology & Regenerative Medicine at the University of Maryland, School of Medicine. Dr. Nestor received his Ph.D. in Neuroscience from The University of Maryland, School of Medicine and completed postdoctoral fellowships at the National Institutes of Health, Rutgers University as an NIH IRACDA Fellow, and at The New York Stem Cell Foundation, where he was also a Staff Scientist. Dr. Nestor is an Early Career Policy Ambassador for The Society for Neuroscience and Volunteer at The University of Maryland, UM Ventures-Department of Technology Transfer. Dr. Nestor is a neurophysiologist with 15 years of experience and a focus on electrophysiology, neural stem cell biology and project management. His laboratory works on assay development with an emphasis on the development of cell based pre-clinical high content drug screens and phenotyping assays involving both 2D and 3D human iPSC-derived neurons from individuals with autism.
                      • Rakhi Pal
                        Chief Technology Scientist, Centre for Brain development and Repair, Instem, Bangalore
                        Biography
                          Dr. Rakhi Pal is the Chief technology scientist at the Centre for Brain Development and Repair, Institute of Stem cell biology and Regenerative medicine, Bangalore,India where she works on using stem cell based technologies to develop platforms for understanding neuro-developmental disorders. A Gold medalist in Human Physiology from the prestigious All India Institute of Medical Sciences, New Delhi and a PhD from Manipal University, Dr Pal has more than 10 years of experience in the field of stem cell biology with particular interest in neurological disorders. She not only has multiple publications and patents to her name, but also possesses an unique blend of both industry and academic experiences.
                        • Daniel Paull
                          Chief Technology Scientist, Centre for Brain development and Repair, Instem, Bangalore
                          Biography
                            Dr. Paull is Vice President, Automation Systems and Stem Cell Biology at The NYSCF Research Institute. Daniel oversees the day-to-day operation of The NYSCF Global Stem Cell Array in both the production of induced pluripotent stem cells and development of novel tools using the robotic platform including such areas as gene editing and differentiation. He also oversees a number of collaborative projects aimed at developing research across a range of disease areas. He received his PhD from University College London, England and followed this with post-doctoral work at the New York Stem Cell Foundation where he helped develop novel approaches for the treatment of mitochondrial disease as well as furthered research into somatic cell nuclear transfer.
                          • Stevens Rehen
                            Head of Research Professor of Biomedical Sciences, D'Or Institute for Research and Education (IDOR) & Institute of Biomedical Sciences Federal University of Rio de Janeiro
                            Biography
                              Stevens Rehen received his Bachelor's degree, Master's degree, and Ph.D. at the Federal University of Rio de Janerio in Brazil. He later completed postdoctoral training at the University of California San Diego and The Scripps Research Institute. Over the past five years, Stevens has published over 76 peer-reviewed publications. Currently, Stevens is a Full Professor at the Federal University of Rio de Janerio. Additionally, he is the Head of Research at D'Or Institute for Research and Education (IDOR) and Regional Committee Member of the Pew Latin American Program in the Biomedical Sciences
                            • Filip Roudnicky
                              Senior Scientist, Roche
                              Biography
                                Filip Roudnicky is a senior scientist in the disease relevant cellular assay team in chemical biology at Roche. His is responsible for genome editing for disease modeling and for CRISPR/Cas9 genetic screens. He is also expert on disease relevant cellular assays involving endothelial cells. Filip started his career with a PhD in a lab of Prof. M. Detmar at ETH Zurich. He studied tumor angiogenesis of invasive bladder carcinoma and identified several biomarkers and molecular targets on tumor-associated blood vessels of bladder cancer. As a guest research scientist he has worked, in RIKEN Yokohama, Japan, under Dr. Jay W. Shin, on induced-neuronal stem cells and RNA-sequencing analysis. He has been a postdoctoral fellow in Roche and Harvard with the lab of Prof. C. Cowan developing an in vitro model of retinal endothelial cells.
                              • Kris Saha
                                Assistant Professor, Department of Biomedical Engineering, Wisconsin Institute for Discovery, University of Wisconsin-Madison
                                Biography
                                  Krishanu Saha is an Assistant Professor in the Department of Biomedical Engineering at the University of Wisconsin-Madison. He is also a member of the Wisconsin Institute for Discovery, Carbone Cancer Center, and Stem Cell and Regenerative Medicine Center as well as the National Academies' Forum on Regenerative Medicine. Prior to his arrival in Madison, Dr. Saha studied Chemical Engineering at Cornell University and at the University of California in Berkeley. He was a Society in Science: Branco-Weiss fellow at the Whitehead Institute for Biomedical Research at MIT and in the Science and Technology Studies program at Harvard University. Major thrusts of his lab involve gene editing and cell engineering of human cells found in the retina, central nervous system and blood.
                                • Ashleigh Schaffer
                                  Assistant Professor, Department of Genetics and Genome Sciences, Case Western Reserve University
                                  Biography
                                    Ashleigh Schaffer graduated with a B.S. in Genetics from University of Wisconsin-Madison and went on to earn her Ph.D. from the University of California, Irvine under the mentorship of Dr. Maike Sander. She continued her training as a postdoctoral fellow at the University of California, San Diego, and Howard Hughes Medical Institute under the guidance of Dr. Joseph G. Gleeson, focused on elucidating the genetic cause, and molecular mechanisms, underlying recessive pediatric neurological disease. During her time with Dr. Gleeson, Ashleigh discovered over 20 novel genetic causes of disease, many for recessive, syndromic pediatric neurodegenerative disorders. She joined the Department of Genetics and Genomes Sciences at Case Western Reserve University as an Assistant Professor in February 2017.
                                  • BanuPriya Sridharan
                                    Postdoctoral Research Associate, Lead ID, The Scripps Research Institute
                                    Biography
                                      Banu Priya Sridharan, PhD, is a Postdoctoral Research Associate at the Scripps Research Institute Molecular Screening Center in the department of Molecular Medicine at Scripps in Florida. After a brief stint in MIT-Harvard HST as an undergraduate research assistant, she trained as a tissue engineer in Lawrence, Kansas where she obtained her Ph.D. in 2015. She moved to Medimmune to do a short-term industrial fellowship. She began at Scripps Florida in 2016 to advance her expertise on developing stem-cell based tissue models but now in the context of HTS. Dr. Sridharan pursued her passion for employing cellular models for phenotypic screening and is deeply involved in iPSC-based neuronal differentiation protocols, genome editing for disease modeling and relevant drug screening. Since 2011, she has published numerous peer reviewed articles and conference posters and podium talks and her key expertise includes stem cell differentiation, phenotypic assay development, high throughput screening and high content analysis.
                                    • Lincon Stamp
                                      ARC DECRA Fellow, University of Melbourne
                                      Biography
                                        Dr. Lincon Stamp did his undergrad degree, BSc (Biotechnology) at the University of Newcastle (Australia). Here he developed a strong interest in stem cell biology and so moved to Melbourne to do Honours and then PhD with Prof Martin Pera at Monash University. Here his research involved investigation of the early differentiation of human embryonic stem cells toward hepatopancreatic cell fates. He then joined the lab of Dr. Don Newgreen at the Murdoch Children's Research Institute where he began working on development of the enteric nervous system, before joining Prof Heather Young's lab at the University of Melbourne Department of Anatomy and Neuroscience, where he has been focused on developing a stem cell therapy to treat gut motility disorders such as the pediatric enteric neuropathy Hirschprung disease. Lincon is an ARC DECRA Fellow and holds an NHMRC Project Grant as CIB with Prof Young, and has recently published a number of high impact studies in the Gastroenterology, Journal of Clinical Investigation and Stem Cell Reports.
                                      • Takanori Takebe
                                        Associate Director, CuSTOM, Professor and Assistant Professor, Cincinnati Children's Hospital Tokyo Medical and Dental University Yokohama City University, Principal Investigator, Takeda-CiRA
                                        Biography
                                          Dr. Takebe is an Associate Director of Center for Stem Cell and Organoid Medicine (CuSTOM) at the Cincinnati Children's Hospital Medical Center and Professor at Yokohama City University, and Tokyo Medical and Dental University, Japan. He serves as Board of Directors at International Society of Stem Cell Research (ISSCR). His lab investigates the mechanisms of human organogenesis, and develops mini-organ technologies from human stem cells - namely organ bud based approaches. He is applying iPSC-liver buds into drug discovery study as well as transplant application - for patients with a rare congenital metabolic disorder, ultimately expanding the clinical indications to diseases like liver cirrhosis.
                                        • Christina Waters
                                          CEO/Founder, RARE Science
                                          Biography
                                            Dr. Christina Waters' broad range of experience in leading medical research in both biotech/large pharmaceutical companies to non-profits converge to specialize in new approaches to personalized medicine and implementation of new innovative research initiatives to accelerate treatments to patients. She serves as SVP and GM of the Global Rare Disease Program at WuXi NextCODE and Founder/CEO of RARE Science, a non-profit research organization that accelerates discovery of therapeutic solutions for kids with rare disease. She serves as a Scientific Advisory board member, for Global Genes, which focuses on rare disease advocacy. Dr. Waters received her Ph.D. in Genetics from UC Davis and was a Postdoctoral Scholar and Associate of the Howard Hughes Medical Institute, California Institute of Technology. Dr. Waters completed an NIH Postdoctoral fellowship at University of California, Berkeley, and received a BS degree from San Diego State University. Dr. Waters received her MBA from UCLA.
                                          Education

                                          What educational opportunities can you find at this year’s event?

                                          NEW! Education Center
                                          This year, 24 Hours of Stem Cells will be introducing an Education Center where you can access virtual and behind-the-scenes training, technical support, handbooks, career development resources and more.

                                          Event Certification
                                          Participate in a variety of activities throughout the live event to collect points and earn a certification of completion.

                                          Training Opportunities
                                          There will be a number of training opportunities including a number of virtual training labs and, new this year, behind-the-scenes live training with our stem cell experts.

                                          Technical Support
                                          Our stem cell experts will be live throughout the virtual event to answer your stem cell questions. Connect with them for the latest stem cell tips and tricks.

                                          Scientific presentations
                                          Hear from over 30 prominent researchers and thought leaders in the industry, both live and on-demand, to expand your stem cell knowledge.

                                          Help

                                          General LabRoots Questions

                                          For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                          Contact us

                                          Virtual Events and Webinars

                                          Supported Configurations

                                          • Operating System Internet Explorer Firefox Chrome Safari
                                            Vista IE8+ FF10+ Chrome15+
                                            Windows 7 IE8+ FF10+ Chrome15+
                                            Windows 8 IE10 FF10+ Chrome15+
                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                          • Cookie settings: session cookies enabled
                                          • Browser configuration must have JavaScript enabled
                                          • Adobe Flash player 10.2 or later

                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                          Internet Connection

                                          • A minimum of 100Kbps is recommended for audio-only events
                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                          Computer Equipment

                                          • Screen Resolution: Minimum 1024x768
                                          • Video Card: 65,000 colors minimum
                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                          • Audio Card: 16-bit minimum
                                          • RAM: 512MB of free RAM

                                          Firewall Protocol

                                          • HTTP on port 80 or HTTPS on port 443
                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                          Work-At-Home Attendees

                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                          For A Seamless Experience

                                          When using a mobile device, FREE Mobile Apps are available:

                                          - For viewing Webinars:

                                          - For viewing Virtual Events

                                          Attendee Guide

                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                          Virtual Event and Webinar Support:

                                          Continuing Education (CME/CE) Support

                                          Loading Comments...